NIOX Group (LON:NIOX) Announces Earnings Results

NIOX Group (LON:NIOX) posted its quarterly earnings results on Wednesday. The company reported GBX 1.41 earnings per share for the quarter, Digital Look Earnings reports. NIOX Group had a return on equity of 10.01% and a net margin of 14.74%.

NIOX Group Stock Down 4.3%

Shares of LON NIOX traded down GBX 3 during trading hours on Thursday, hitting GBX 66. The company had a trading volume of 215,753 shares, compared to its average volume of 799,601. NIOX Group has a 1-year low of GBX 53.84 and a 1-year high of GBX 76. The company has a quick ratio of 1.94, a current ratio of 4.60 and a debt-to-equity ratio of 1.06. The firm’s 50 day moving average is GBX 65.69 and its 200-day moving average is GBX 61.63. The stock has a market capitalization of £277.77 million, a P/E ratio of 40.24 and a beta of 0.92.

About NIOX Group

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.